Related Experiment Video
Updated: Apr 4, 2026

06:46
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
3.4K
Early Gestational Diabetes Mellitus: Screening and Management.
1Dell Medical School, The University of Texas at Austin, Austin, TX.
Clinical Obstetrics and Gynecology
|April 3, 2026
Summary
Gestational diabetes (GDM) is rising due to increased maternal age and obesity. Early screening before 20 weeks is gaining interest, but limited evidence and diagnostic criteria hinder clinical guidance.
Area of Science:
- Obstetrics and Gynecology
- Endocrinology
- Maternal-Fetal Medicine
Background:
- Increasing rates of maternal age and obesity in reproductive-aged women are linked to a rise in gestational diabetes.
- This trend necessitates broader screening for glycemic dysfunction during pregnancy.
- Current clinical guidance for screening and diagnosis before 20 weeks of gestation is limited by insufficient high-quality evidence and non-uniform diagnostic criteria.
Purpose of the Study:
- To summarize current approaches to screening and diagnosing gestational diabetes mellitus (GDM) before 20 weeks of gestation.
- To address the growing need for early detection of glycemic dysfunction in pregnancy.
- To highlight the limitations in clinical guidance due to evidence and criteria gaps.
Main Methods:
- Literature review of studies on screening and diagnosis of GDM before 20 weeks.
- Synthesis of available evidence on early glycemic dysfunction detection.
- Analysis of diagnostic criteria and their uniformity.
Main Results:
- The review synthesizes current data on early GDM screening and diagnosis.
- Identifies key challenges including lack of robust evidence and standardized criteria.
- Highlights the growing interest in detecting pre-existing or early GDM.
Conclusions:
- Early screening for gestational diabetes before 20 weeks is increasingly relevant.
- Standardized diagnostic criteria and high-quality evidence are crucial for improved clinical practice.
- Further research is needed to establish effective early screening protocols for GDM.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
5.6K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.6K
Pathophysiology of Diabetes
4.4K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.4K
Diabetes: Symptoms, Diagnosis, and Complications
2.8K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.8K
Diabetes: Management and Pharmacotherapy
1.5K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K
Hypoglycemia and Glucagon
1.3K
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.3K
Diabetes Mellitus: Overview and Type I Subtype
6.0K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
6.0K

